Recro to Present at Oppenheimer Fall Healthcare Life Sciences & Medtech Summit

Rhea-AI Summary

Recro (Nasdaq:REPH), a prominent contract development and manufacturing organization, announced that CEO Gerri Henwood will present at the Oppenheimer Fall Healthcare Life Sciences & Medtech Summit on September 22, 2020, at 4:10 p.m. ET. A live webcast of the presentation will be accessible on Recro's Investors page, and a replay will be available for 30 days post-event. Recro specializes in the development and manufacturing of high-potency oral solid dose drug products, providing comprehensive solutions for its partners.

GAINESVILLE, Ga., Sept. 18, 2020 (GLOBE NEWSWIRE) -- Recro (Nasdaq:REPH), a leading contract development and manufacturing organization (CDMO), with integrated solutions for the development, formulation, regulatory support, manufacturing and packaging of oral solid dose drug products, today announced that Gerri Henwood, the Company’s President and Chief Executive Officer, will present at the Oppenheimer Fall Healthcare Life Sciences & Medtech Summit on Tuesday, September 22, 2020 at 4:10 p.m. ET.

A live webcast of the presentation will be available on the “Presentations” page within the Investors section of the Recro website at https://ir.recropharma.com. A replay will be available on the Recro website for a period of 30 days following the event.

About Recro

Recro is a contract development and manufacturing, or CDMO, business, with integrated solutions for the development, formulation, manufacturing and CTM management of high potency and other  solid oral dose forms and located in Gainesville, GA. The Company leverages its formulation expertise to develop and manufacture pharmaceutical products using its proprietary delivery technologies and other manufacturing services for commercial and development-stage partners who commercialize or plan to commercialize these products. For more information see www.recropharma.com.

Contacts

Investor Relations Contact:
Argot Partners
Sam Martin / Claudia Styslinger
(212) 600-1902
sam@argotpartners.com
Claudia@argotpartners.com

Recro
Ryan D. Lake
(484) 395-2436
rlake@recropharma.com

Media Contact:
Argot Partners
David Rosen
(212) 600-1902
David.rosen@argotpartners.com

FAQ

When will Recro present at the Oppenheimer Fall Healthcare Life Sciences & Medtech Summit?

Recro will present on September 22, 2020, at 4:10 p.m. ET.

Where can I watch the Recro presentation live?

The live webcast of the Recro presentation can be found on the 'Presentations' page of their Investors section at their website.

How long will the Recro presentation replay be available?

The replay of the Recro presentation will be available for 30 days after the event.

What does Recro specialize in?

Recro specializes in contract development and manufacturing for high-potency oral solid dose drug products.

What is the stock symbol for Recro?

The stock symbol for Recro is REPH.